These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 18715406
1. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. Donders GG, Babula O, Bellen G, Linhares IM, Witkin SS. BJOG; 2008 Sep; 115(10):1225-31. PubMed ID: 18715406 [Abstract] [Full Text] [Related]
2. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. Clin Infect Dis; 2003 Sep 01; 37(5):733-7. PubMed ID: 12942410 [Abstract] [Full Text] [Related]
4. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis. Wojitani MD, de Aguiar LM, Baracat EC, Linhares IM. Arch Gynecol Obstet; 2012 Jan 01; 285(1):149-53. PubMed ID: 21655939 [Abstract] [Full Text] [Related]
5. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC. N Engl J Med; 2004 Aug 26; 351(9):876-83. PubMed ID: 15329425 [Abstract] [Full Text] [Related]
6. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R, Stalpaert M, Vereecken A, Van Eldere J. Am J Obstet Gynecol; 2008 Dec 26; 199(6):613.e1-9. PubMed ID: 18976735 [Abstract] [Full Text] [Related]
7. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy. Ventolini G, Baggish MS, Walsh PM. J Reprod Med; 2006 Jun 26; 51(6):475-8. PubMed ID: 16846086 [Abstract] [Full Text] [Related]
8. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)]. Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L. Akush Ginekol (Sofiia); 2005 Jun 26; 44 Suppl 2():25-7. PubMed ID: 16028400 [Abstract] [Full Text] [Related]
9. Mannose-binding lectin and vulvovaginal candidiasis. Liu F, Liao Q, Liu Z. Int J Gynaecol Obstet; 2006 Jan 26; 92(1):43-7. PubMed ID: 16256117 [Abstract] [Full Text] [Related]
10. Mannose-Binding Lectin Gene Polymorphism and Its Association with Susceptibility to Recurrent Vulvovaginal Candidiasis. Hammad NM, El Badawy NE, Nasr AM, Ghramh HA, Al Kady LM. Biomed Res Int; 2018 Jan 26; 2018():7648152. PubMed ID: 29850562 [Abstract] [Full Text] [Related]
11. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment. Ventolini G, Baggish MS. Maturitas; 2005 Jul 16; 51(3):294-8. PubMed ID: 15978973 [Abstract] [Full Text] [Related]
12. [Fluconazole for recurrent vulvovaginal candidiasis]. Tietz HJ. Med Monatsschr Pharm; 2009 Jun 16; 32(6):227. PubMed ID: 19554833 [No Abstract] [Full Text] [Related]
13. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)]. Borisov I, Kolarov G, Bobcheva S, Ivanova A. Akush Ginekol (Sofiia); 2005 Jun 16; 44 Suppl 2():17-20. PubMed ID: 16028398 [Abstract] [Full Text] [Related]
14. Chronic vulvovaginal candidiasis. Eschenbach DA. N Engl J Med; 2004 Aug 26; 351(9):851-2. PubMed ID: 15329419 [No Abstract] [Full Text] [Related]
15. Mannose-binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta-analysis. Nedovic B, Posteraro B, Leoncini E, Ruggeri A, Amore R, Sanguinetti M, Ricciardi W, Boccia S. Biomed Res Int; 2014 Aug 26; 2014():738298. PubMed ID: 25143944 [Abstract] [Full Text] [Related]
16. Treatment of recurrent vulvovaginal candidiasis. Ringdahl EN. Am Fam Physician; 2000 Jun 01; 61(11):3306-12, 3317. PubMed ID: 10865926 [Abstract] [Full Text] [Related]
17. Vulvovaginal candidiasis in a Flemish patient population. De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ. Clin Microbiol Infect; 2005 Dec 01; 11(12):1005-11. PubMed ID: 16307555 [Abstract] [Full Text] [Related]
18. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B. Am J Obstet Gynecol; 2004 Mar 01; 190(3):644-53. PubMed ID: 15041994 [Abstract] [Full Text] [Related]
19. MBL2 genetic screening in patients with recurrent vaginal infections. Milanese M, Segat L, De Seta F, Pirulli D, Fabris A, Morgutti M, Crovella S. Am J Reprod Immunol; 2008 Feb 01; 59(2):146-51. PubMed ID: 18211540 [Abstract] [Full Text] [Related]
20. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Babula O, Lazdāne G, Kroica J, Linhares IM, Ledger WJ, Witkin SS. Clin Infect Dis; 2005 May 01; 40(9):1258-62. PubMed ID: 15825027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]